Radziowi

Radziowi is a Polish biotechnology company focused on the development of innovative therapies for the treatment of chronic and neuropathic pain. The company specializes in the design and synthesis of novel small molecules and peptide-based compounds that target specific receptors involved in pain signaling. Their research efforts are primarily directed toward creating safer and more effective alternatives to traditional opioid analgesics, aiming to minimize side effects and the risk of addiction. Radziowi leverages its expertise in medicinal chemistry and pharmacology to advance its proprietary pipeline through early-stage discovery and pre-clinical validation. The company is actively involved in collaborative research projects within the European biotech ecosystem to accelerate the translation of its scientific findings into clinical applications.